期刊文献+

多学科合作模式在胃肠间质瘤诊治中的价值与实施 被引量:11

Value and application of multidisciplinary modality in the diagnosis and treatment of gastrointestinal stromal tumor
原文传递
导出
摘要 肿瘤的治疗原则已经由单一的外科治疗演变为多学科共同参与的综合治疗。多学科团队协作(MDT)的诊治模式已经在包括乳腺癌、结直肠癌、胃癌等疾病中得到了应用并取得了成功。胃肠间质瘤(GIST)是胃肠道最常见的间叶源性肿瘤,随着分子靶向治疗时代的到来.GIST的诊断治疗也越来越专业化和个体化.MDT模式在GIST的诊断和治疗上尤其显得更加重要和必要. Treatment of cancer has evolved from surgical intervention towards muhidisciplinary team (MDT) approach. The effect of MDT treatment modality on cancer is significantly better than that of conventional treatment modality. Obvious achievements have been made in breast cancer, colorectal cancer, and gastric cancer using the MDT model. Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. With the success in GIST, molecular targeted therapy has become more and more specialized and individualized to manage this tumor. MDT modality is especially important in the diagnosis and treatment of GIST.
作者 曹晖 汪明
出处 《中华胃肠外科杂志》 CAS 2012年第3期231-233,共3页 Chinese Journal of Gastrointestinal Surgery
基金 上海市科学技术委员会资助课题(11411950800) 仁济医院学科建设项目(RJ4101304)
关键词 胃肠间质瘤 多学科 诊断 治疗 Gastrointestinal stromal tumors Multidisciplinary Diagnosis Treatment
  • 相关文献

参考文献12

  • 1Demetri GD, yon Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw, 2010,8(Suppl 2) :S1-41.
  • 2Casali PG, Jost L, Reichardt P, et al. Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol, 2009,20 (Suppl 4):64- 67.
  • 3Novitsky YW, Kercher KW, Sing RF, et al. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg, 2006,243 (6) : 738-745.
  • 4Yano H, Kimura Y, Iwazawa T, et al. Hand-assisted laparoscopic surgery for a large gastrointestinal stromal tumor of the stomach. Gastric Cancer, 2005,8(3):186-192.
  • 5Eisenberg BL, Harris J, Blanke CD, et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol, 2009,99 ( 1 ) : 42-47.
  • 6Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol, 2002,10(2) :81-89.
  • 7Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach : a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol, 2005,29( 1 ) : 52-68.
  • 8Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol, 2008,39(10) : 1411- 1419.
  • 9侯英勇,朱雄增.胃肠间质瘤恶性程度的判断及其对预后的影响[J].中国实用外科杂志,2010,30(4):265-269. 被引量:17
  • 10Dematteo RP, Ballman KV, Antonescu CR, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet, 2009,373(9669) : 1097-1104.

二级参考文献1

共引文献105

同被引文献123

引证文献11

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部